We perform a complete DNA/RNA analysis of the tumour to find new treatment options.
DNA profiling on tumour samples allows for the identification of thousands of mutations that can be linked to 780 target therapies and immunotherapies.
Our scientists and geneticists are able to advise on the most appropriate test for the specific case and perform a complete mutational analysis in less than 15 days.
Request free consultancy.
Get testing rates and conditions
Oncologica® is a leading precision oncology certified laboratory based in the prestigious Chesterford Research Park, Cambridge, UK. Since 2015 we have been helping oncologists and patients every day to get the maximum benefit from new advanced genetic profiling techniques for the treatment of cancer.
“We provide cancer patients with personalised treatment options based on their unique tumour DNA profile”
What is a genetic test on tumour sample?
Tumours are unique because they are different kinds of DNA mutations obtained during cancer development. Therefore, treatment doesn’t work the same way for everyone. DNA profiling enables doctors to identify therapy options that are likely to offer the most successful outcomes. This evolution of DNA profiling has enabled the use of an individual’s DNA profile to target particular mutations in cancer.
Our testing options available for cancer patients:
Which types of tumours are eligible for DNA testing
and correlation to the best targeted therapies?
- bladder cancer
- brain cancer
- breast cancer
- colon cancer
- kidney cancer
- liver cancer
- lung cancer
- neck cancer
- ovarian cancer
- pancreatic cancer
- prostate cancer
- skin cancer
- stomach cancer
- uterine cancer
.. AND 100+ SOLID TUMOUR TYPES
A great team of genetists, phatologist and oncologists to
help you and your doctor to find a tailored theraphy.
CO-FOUNDER AND SCIENTIFIC DIRECTOR
LEAD CLINICAL SCIENTIST
LABORATORY AND QUALITY MANAGER
Can Oncofocus Test help me? Get a free advice today!
Book a free consultation call with our Clinical Team to obtain more information on suitability for testing.